Management Team
- View Details
Professor
Patrick TanExecutive Director, PRECISEProfessor
Patrick TanExecutive Director, PRECISEProf. Patrick Tan is the Executive Director of PRECISE. As Executive Director of PRECISE, Prof Tan will oversee the implementation of Phase II of Singapore’s Precision Medicine Strategy, which aims to transform healthcare in Singapore and improve patient outcomes through new insights into the Asian genome and data-driven healthcare solutions.
During the 2020 COVID-19 pandemic, he was Program Director of Operation Stronghold, establishing one of Singapore’s largest COVID-19 testing facilities through a joint effort involving A*STAR (Agency for Science, Technology and Research), National University Health System, and Temasek Holdings.
Prof Tan is also Senior Vice Dean (Research) at Duke-NUS Medical School and Chief Scientific Officer at the Genome Institute of Singapore, Agency for Science, Technology and Research (A*STAR). He received his B.A. (summa cum laude) from Harvard University and MD PhD degree from Stanford University, where he received the Charles Yanofsky prize for Most Outstanding Graduate Thesis in Physics, Biology or Chemistry.
Other awards include the President’s Scholarship, Loke Cheng Kim scholarship, Young Scientist Award (A-STAR), Singapore Youth Award (twice), Chen New Investigator Award (Human Genome Organization), President’s Science Award, and the Japanese Cancer Association International Award. In 2018, he received the American Association for Cancer Research (AACR) Team Science Award as Team Leader, representing the first time a team from Asia has received the award. He is an elected member of the American Society for Clinical Investigation (ASCI), the Bioethics Advisory Committee (BAC), a Board Member of the International Gastric Cancer Association, and on the Board of Reviewing Editors for Science.
- View DetailsProfessor
Tai E ShyongChief Medical Officer, PRECISEProfessor
Tai E ShyongChief Medical Officer, PRECISEProf Tai E Shyong, MD underwent medical training at the University of Dundee in the United Kingdom. He is a Fellow of the Royal College of Physicians in the United Kingdom and a Fellow of the Academy of Medicine in Singapore (Endocrinology). Prof Tai is currently a Professor in the Department of Medicine at the Yong Loo Lin School of Medicine, the Saw Swee Hock School of Public Health and Duke-NUS Graduate Medical School. Prof Tai has also served on the committees that write the clinical practice guidelines for the Ministry of Health in the areas lipids and diabetes mellitus.
Prof Tai has a longstanding interest in the development of novel treatments for diabetes mellitus that leverages on human genetics for the identification of novel drug targets and has published over 200 articles in peer reviewed journals.
As CMO, Prof Tai will identify precision medicine applications that are relevant to Singapore and design clinical workflows for their use as part of mainstream clinical practice.
- View DetailsProfessor
John ChambersChief Scientific Officer, PRECISEProfessor
John ChambersChief Scientific Officer, PRECISEJohn Chambers is Professor of Cardiovascular Epidemiology at both LKCMedicine, NTU and Imperial College London, UK. He is also Director of the ‘Centre for Global Health Research’ at LKCMedicine, and of the ‘NIHR Global Health Research Unit for Diabetes and Cardiovascular Disease in South Asians’ at Imperial College London. Professor Chambers leads unique, large scale prospective population studies in South East Asia – (Singapore, the ‘SG100K study’), South Asia (India, Pakistan and Sri Lanka, ‘South Asia Biobank’) – and in the UK, that together include >300,000 participants. His personal research is focused on identifying the mechanisms underlying diabetes and premature cardiovascular disease in Asian populations. He also leads translational research that aims to improve health promotion and disease prevention, using personalised and population-based approaches.
As CSO, Prof Chambers will set the research direction and strategy for PRECISE, so that Singapore achieves its goal of being the world leader in Asian Genomics and Precision Medicine.
- View DetailsDr Seow Shih WeeDirector (Corporate Services), PRECISEDr Seow Shih WeeDirector (Corporate Services), PRECISE
Dr Seow Shih Wee is Director of Corporate Services. As Director, Corporate Services, Dr Seow is responsible for coordinating daily operations across various departments in PRECISE, designing and implementing strategies, working with legal departments to prepare collaboration agreements. Dr Seow also oversees PRECISE public comms, staff hiring and budget management matters, liaising with various government agencies to support PRECISE operations.
Prior to becoming Director of Corporate Services, Dr Seow was at the Agency for Science, Technology and Research (A*STAR) where she was Head (PharmBio) at the Biomedical Research Council, and later on, as Deputy Director, led the Business Development team at the Research Support Centre. As Head (PharmBio), Dr Seow managed and evaluated special research programmes and projects, and she was instrumental in setting up NPM Phase I.
Dr Seow is a microbiologist by training, she obtained her Ph.D. from the National University of Singapore and was a recipient of the NUS Graduate Student Fellowship.